Skip to main content

KONINKLIJKE PHILIPS NV

For the period ended Dec 31, 2025. Filed Feb 19, 2026.

View on SEC.gov

About this filing

The yearly report of a company based outside the US. It covers much of what a 10-K does, and may follow accounting rules other than US ones.

FY2025 · Filed Feb 19, 2026

PHG$30.35-0.5%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits
Contents

Form 20-F cross reference table

Only the following information shall be deemed to be filed with the Securities and Exchange Commission for

any purpose (i) the information in this document that is referenced in the Form 20-F cross reference table, (ii)

the Introduction and the cautionary statements concerning forward-looking statements of this report on

pages 7-8, and (iii) the Exhibits. The content of Philips websites and other websites referenced herein should

not be considered to be a part of or incorporated into the 2025 Form 20-F. Any additional information which

is not referenced in the Form 20-F cross reference table or the Exhibits themselves shall not be deemed to be

so incorporated by reference, shall not be part of the 2025 Form 20-F and is furnished to the Securities and

Exchange Commission for information only.

The table below sets out the location in this document of the information required by SEC Form 20-F. The

exact location is included in the column ‘Location in this document’. The page number refers to the starting

page of the section for reference only (and is not intended to refer to the starting page of the specific

subsection, if applicable).

ItemForm 20-F captionLocation in this document
1Identity of directors, senior management and advisorsNot applicable
2Offer statistics and expected timetableNot applicable
3Key information
A [Reserved]Not applicable
B Capitalization and indebtednessNot applicable
C Reason for the offer and use of proceedsNot applicable
D Risk factorsRisk factors
Strategic risks
Operational risks
Financial and reporting risks
Compliance risks
Factors impacting performance
ItemForm 20-F captionLocation in this document
4Information on the Company
A History and development of the companyCover
Introduction – Documents on display
Strategy – Strategic focus
Our Business structure
Business – Connected Care segment
Factors impacting performance – Operating model
Results of operations – Discontinued operations
Results of operations – Restructuring, acquisition-related charges and other items
Acquisitions and divestments
Cash flows
Corporate governance
Other Corporate governance
Corporate information
Investor contact – How to reach us
Note 3 – Discontinued operations and assets classified as held for sale
Note 4 – Acquisitions and divestments
Note 5 – Interests in entities
Note 30 – Subsequent events
B Business OverviewIntroduction – Third-party market share data
Strategic focus
Our Business structure
Business – Our business structure; Diagnosis and Treatment segment; Connected Care segment; Personal Health segment; Segment other
Our Regions
Supply chain and procurement
Performance Summary (excluding the information set forth under the subheading "Outlook")
Results of operations – Sales per geographic area
Patient safety, quality and regulatory and the Medical Office
Note 2 – Information by segment and main country
ItemForm 20-F captionLocation in this document
C Organizational structureOur Business structure
Note 5 – Interests in entities
D Property, plant and equipmentOur Business structure – Central costs; Innovation and design
Our Regions – 2025 developments North America; 2025 developments Greater China
Note 2 – Information by segment and main country
Note 3 – Discontinued operations and assets classified as held for sale - Assets classified as held for sale
Note 10 – Property, plant and equipment
Note 19 – Provisions - Environmental provisions
Note 24 – Contingencies - Environmental remediation
4AUnresolved staff commentsNot applicable
5Operating and financial review and prospects
A Operating resultsSupply chain and procurement
Performance Summary (excluding the information set forth under the subheading "Outlook")
Factors impacting performance
Results of operations
Results of operations – Restructuring, acquisition-related charges and other items
Acquisitions and divestments
Other key performance indicators
Note 1 – General information to the Consolidated financial statements - Foreign currency transactions: Foreign operations
Note 3 – Discontinued operations and assets classified as held for sale
Note 4 – Acquisitions and divestments
Note 6 – Income from operations
Note 7 – Financial income and expenses
Note 8 – Income taxes - Deferred tax assets and liabilities
Note 11 – Goodwill
Note 12 – Intangible assets excluding goodwill
Note 20 – Post-employment benefits
Note 24 – Contingencies
Note 29 – Details of treasury and other financial risks - Currency risk
Note 30 – Subsequent events
ItemForm 20-F captionLocation in this document
B Liquidity and capital resourcesOur Regions – 2025 developments North America
Financial position – Debt position
Financial performance – Supply chain resilience
Cash flows
Liquidity position
Cash obligations
Note 17 – Equity
Note 18 – Debt
Note 23 – Cash flow statement supplementary information
Note 29 – Details of treasury and other financial risks
C Research and development, patents and licenses, etc.Strategic focus
Business – Innovation & Design; IP Royalties
Business – 2025 developments North America; 2025 developments Greater China
Results of operations – Research and development expenses
Financial performance – Supply chain resilience
Cash flows
D Trend informationSupply chain and procurement
Factors impacting performance
Reconciliation of non-IFRS information
Other Key Performance Indicators
E Critical accounting estimatesNot applicable
6Directors, senior management and employees
A Directors and senior managementMembers of the Board of Management and Executive Committee – Members of the Board of Management
Members of the Supervisory Board
Board of Management and Executive Committee – Appointment and composition
Supervisory Board – Appointment and composition
ItemForm 20-F captionLocation in this document
B CompensationRemuneration report 2025
Remuneration report 2025 – Letter from the Remuneration Committee Chair
Remuneration report 2025 – Board of management
Note 26 – Share-based compensation
Note 27 – Information on remuneration
C Board practicesMembers of the Supervisory Board
Members of the Board of Management and Executive Committee – Members of the Board of Management
Governance – Annual financial statements and external audit
Supervisory Board report – Supervisory Board Committees
Report of the Audit Committee
Remuneration report 2025 – Letter from the Remuneration Committee Chair, Main elements of the Remuneration Policy; Services agreements
Board of Management and Executive Committee – Appointment and composition
Supervisory Board – Appointment and composition; Supervisory Board committees
Other Corporate governance – Committees of our Supervisory Board
D EmployeesEmployment
Note 6 – Income from operations – Employees
E Share ownershipRemuneration report 2025 – Historical LTI grants and holdings
Other Board-related matters – Remuneration and share ownership
Further information – Voting rights; Equity compensation plans
Note 26 – Share-based compensation
Note 27 – Information on remuneration - Supervisory Board members’ and Board of Management members’ interest in Philips shares
F Disclosure of registrant's action to recover erroneously awarded compensationNot applicable
ItemForm 20-F captionLocation in this document
7Major shareholders and related party transactions
A Major shareholdersGeneral Meeting of Shareholders – Share capital; issue and repurchase of (rights to) shares (second and third paragraphs)
Stichting Preferente Aandelen Philips
Major shareholders
Other Corporate governance – Voting Rights (last sentence)
B Related party transactionsOther Board-related matters – Conflicts of interest; Remuneration and share ownership (fifth paragraph)
Note 5 – Interests in entities
Note 25 – Related-party transactions
C Interests of experts and counselNot applicable
8Financial information
A Consolidated statements and other financial informationDividend – Dividend policy
Group financial statements
B Significant changesNote 30 – Subsequent events
9The offer and listing
A Offer and listing detailsShare information
B Plan of distributionNot applicable
C MarketsShare information
D Selling shareholdersNot applicable
E DilutionNot applicable
F Expenses of the issueNot applicable
10Additional information
A Share capitalNot applicable
B Memorandum and articles of associationBoard of Management and Executive Committee – Appointment and composition
Supervisory Board – Appointment and composition
Other Board-related matters – Remuneration and share ownership (fifth paragraph); Conflicts of interest
ItemForm 20-F captionLocation in this document
General Meeting of Shareholders – Meetings; Main powers of the General Meeting of Shareholders
Stichting Preferente Aandelen Philips
Other Corporate governance – Articles of association
C Material contractsRemuneration report 2025 – Letter from the Remuneration Committee Chair (sixth paragraph); Services agreements
Board of Management and Executive Committee - Appointment and composition (third paragraph)
Supervisory Board – Appointment and composition (last paragraph)
Note 24 Contingencies - Product liability claims
Note 25 – Related-party transactions
Note 26 – Share-based compensation
Note 27 – Information on remuneration
Index of exhibits – Exhibit 4(a)
Index of exhibits – Exhibit 4(b)
Index of exhibits – Exhibit 4(c)
Index of exhibits – Exhibit 4(d)
Index of exhibits – Exhibit 4(e)
Index of exhibits – Exhibit 4(f)
D Exchange controlsOther Corporate governance – Exchange controls
Note 29 – Details of treasury and other financial risks - Liquidity risk
E TaxationTaxation
F Dividends and paying agentsNot applicable
G Statements by expertsNot applicable
H Documents on displayIntroduction - Documents on display
I Subsidiary informationNot applicable
J Annual Report to Security HoldersThe Company intends to submit any annual report provided to security holders in electronic format as an exhibit to a current report on Form 6-K.
ItemForm 20-F captionLocation in this document
11Quantitative and qualitative disclosure about market risk
A Quantitative information about market riskForward-looking statements
Note 29 – Details of treasury and other financial risks
B Qualitative information about market riskForward-looking statements
Note 29 – Details of treasury and other financial risks
C Interim periodsNot applicable
D Safe harborForward-looking statements
Note 29 – Details of treasury and other financial risks
E Smaller reporting companiesNot applicable
12Description of securities other than equity securities
A Debt securitiesNot applicable
B Warrant and rightsNot applicable
C Other securitiesNot applicable
D American depository sharesOther Corporate governance – New York Registry Shares
13Defaults, dividend arrearages and delinquenciesNot applicable
14Material modifications to the rights of security holders and use of proceedsNot applicable
15Controls and procedures
A Disclosure controls and proceduresDisclosure controls and procedures
B Management's Annual Report on internal control over financial reportingManagement's annual report on internal control over financial reporting
Attestation report of the registered public accounting firm
C Attestation report of the registered public accounting firmAttestation report of the registered public accounting firm
ItemForm 20-F captionLocation in this document
Independent auditor’s report - PricewaterhouseCoopers Accountants N.V. (PCAOB ID: 1395)
D Changes in internal control over financial reportingChanges in internal control over financial reporting
16AAudit Committee Financial ExpertSupervisory Board - Supervisory Board Committees (fifth paragraph)
16BCode of EthicsGeneral Business Principles (GBP) (last paragraph)
16CPrincipal Accountant Fees and ServicesReport of the Audit Committee
Annual financial statements and external audit
Note 6 – Income from operations - Audit and audit-related fees
16DExemptions from the Listing Standards for Audit CommitteesNot applicable
16EPurchases of Equity Securities by the Issuer and Affiliated PurchasersShareholders’ equity – Share repurchase methods for long-term incentive plans and capital reduction purposes
16FChange in Registrant’s Certifying AccountantAnnual financial statements and external audit (second paragraph, last sentence)
16GCorporate GovernanceOther Corporate governance – Significant differences in corporate governance practices
16HMine Safety DisclosureNot applicable
16IDisclosure regarding Foreign Jurisdictions that prevent inspectionsNot applicable
16JInsider Trading PoliciesGeneral Business Principles (GBP)
16KCybersecurityCybersecurity
17Financial statementsNot applicable
18Financial statementsGroup financial statements
19ExhibitsIndex of exhibits

Our management

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.